CorMedix Inc.

CRMD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 19, 2026 CURRENT REPORT
4 Sep 18, 2026
4 Sep 1, 2026
4 Sep 1, 2026
4 Sep 1, 2026
10-Q Aug 13, 2026 10-Q
8-K Aug 13, 2026 8-K
8-K Aug 7, 2026 8-K
8-K Jul 2, 2026 8-K
8-K Jul 1, 2026 8-K
S-8 POS Jun 25, 2026 S-8 POS
8-K Jun 24, 2026 8-K
SCHEDULE 13G/A Jun 12, 2026
SCHEDULE 13G/A Jun 12, 2026
8-K Jun 8, 2026 CURRENT REPORT
SCHEDULE 13G/A May 15, 2026
10-Q May 14, 2026 10-Q
8-K May 14, 2026 8-K
ARS Apr 29, 2026 ARS
DEFA14A Apr 29, 2026 DEFINITIVE ADDITIONAL MATERIALS
DEF 14A Apr 29, 2026 PROXY STATEMENT
8-K Apr 27, 2026 CURRENT REPORT
PRE 14A Apr 17, 2026 PROXY STATEMENT
SCHEDULE 13G/A Mar 26, 2026
8-K Mar 6, 2026 CURRENT REPORT
← Newer Page 1 of 46 · 1135 filings Older →